Skip to main content
← Back to companies
Alto Neuroscience logo

Alto Neuroscience

8 open3 remote
Los Altos, California, United StatesFounded 201979+ employees$421.0M raisedIPOANRO
Last round: post ipo equity · $120M · Mar 2026(13 rounds total)
Founded by Amit Etkin, Dan Segal, Wei Wu
Backed by(38 investors)
Perceptive AdvisorsCommodore CapitalAlkeon CapitalAlpha Wave VenturesApeiron Investment GroupInVivium CapitalK2 HealthVenturesLightswitch CapitalTim KendallWellcome TrustVenrock Healthcare Capital PartnersDellora InvestmentsDriehaus Capital ManagementSpruce Street CapitalVestal Point Capital

Alto Neuroscience is redefining psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective medicines, helping patients get better faster. ​ Alto's Precision Psychiatry Platform™ measures biomarkers like EEG and wearable data, behavioral patterns, genetics, and other factors to match patients with the treatment they are most likely to respond to. Our approach matches the right patient with the right Alto drug based on AI-derived brain biomarkers, redefining psychiatry at a time when the world needs it most.

Ready to start your space career at Alto Neuroscience?

Shipping like we're funded. We're not. No affiliation.

Sequoia logo
Y Combinator logo
Founders Fund logo
a16z logo